Frank Ternes has been appointed chief business officer, responsible for leading the planning, development and execution of all business development, sales, marketing and project management activities at Rentschler Biotechnologie.   Mr. Ternes has more than 25 years of experience from operations and technology positions at Boehringer Ingelheim, where he last served as senior vice president of Biopharmaceutical Contract Manufacturing.   “Mr. Ternes is an excellent addition to Rentschler&#821...